A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Trial ID or NCT#
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma (HCC)
- 1. Male or female patients, age ≥18 years 2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)
- 1. Inability to provide written informed consent
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToSwati Toppo
Go Back To The Trial